Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial - Wikidata - awgldk - TriplyDB

Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial

Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial

http://www.wikidata.org/entity/Q35105984

about

Probiotic supplementation in children with cystic fibrosis-a systematic review.Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings.(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease The dormant blood microbiome in chronic, inflammatory diseases.Archaeal microbiota population in piglet feces shifts in response to weaning: Methanobrevibacter smithii is replaced with Methanobrevibacter boviskoreani.Alteration of the Microbiota and Virulence Gene Expression in E. coli O157:H7 in Pig Ligated Intestine with and without AE Lesions The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent.Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model The Microbiome in Cystic Fibrosis.Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota.CFTR Knockdown induces proinflammatory changes in intestinal epithelial cells.The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials.The Fecal Microbiota Profile and Bronchiolitis in Infants.Feeding bovine milks with low or high IgA levels is associated with altered re-establishment of murine intestinal microbiota after antibiotic treatment Cystic fibrosis from the gastroenterologist's perspective.Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients.Beyond pancreatic insufficiency and liver disease in cystic fibrosis.The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease.The CF gastrointestinal microbiome: Structure and clinical impact.Role of vitamin D on gut microbiota in cystic fibrosis.Microbiomes in respiratory health and disease: An Asia-Pacific perspective.IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.Impact of Omega-3 Fatty Acids on the Gut Microbiota.Novel carbohydrate binding modules in the surface anchored α-amylase of Eubacterium rectale provide a molecular rationale for the range of starches used by this organism in the human gut.Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?Anti-adhesion Property of the Potential Probiotic Strain Lactobacillus fermentum 8711 Against Methicillin-Resistant Staphylococcus aureus (MRSA).New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.Vitamin D attenuates inflammation in CFTR knockdown intestinal epithelial cells but has no effect in cells with intact CFTR.Galacto-Oligosaccharide/Polidextrose Enriched Formula Protects against Respiratory Infections in Infants at High Risk of Atopy: A Randomized Clinical Trial.Correlation of Severity of Functional Gastrointestinal Disease Symptoms with that of Asthma and Chronic Obstructive Pulmonary Disease: A Multicenter Study.Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions.Diet, Microbiota and Gut-Lung Connection Associations between Flavonoid Intakes and Gut Microbiota in a Group of Adults with Cystic Fibrosis

P2860

Q30248234-EB512930-CE9F-46D3-B3E8-BD20841ABD9C Q33470424-DB5563A1-D553-4D3B-99DA-5F38768C42C2 Q33909216-BAA2E48C-8EA7-4068-9502-2909D17DAC17 Q34474989-EE8DBB63-360C-4547-9786-27F6BDB2312B Q35611947-D8227AAA-179D-4BFE-A654-CF1D0B265FC4 Q35668443-633220D0-214B-4008-B46B-8D0F5DEF2E39 Q35880704-D98A116C-3F0B-4180-9EE1-3603E22CC8C9 Q35891069-B6EC2BD0-1670-4AD2-85B9-FA42FF775019 Q35917770-501AD02E-27DE-4265-BCC2-28B93E45C511 Q35945463-EF1C21E2-D627-419F-8149-C2263659F25C Q35955639-9F022F39-CF29-4FDE-97E1-D16AA32BA24A Q36181782-12A8E41E-E338-4BC5-A7E8-52B766698657 Q36259087-0D518441-8F37-412D-941B-A63DFC7EF55E Q36268539-0481CA64-B806-4DE4-B268-8713AE9F3956 Q36362653-E8162A7D-8612-464C-8F31-BCF418311B72 Q37047479-A9EF6E58-A46C-49C4-A7C3-27E13FBD6351 Q37305071-B6D453FB-57A6-4CEE-8D18-6FAC8DA87CF8 Q38704228-88BFFFE1-D2E7-4C9D-BF3B-BCFF77E09E02 Q38769187-26D455A3-BB88-4E4B-8607-43C1B198DFCF Q38800967-FA684450-D16E-43A0-9663-3D0ED842A41A Q38853672-D675DEDA-67B1-4D01-9402-B713F93F26A7 Q38962739-06AC2E06-DDF0-423F-8BFA-0D47D3637C3E Q39000441-E5606BC4-FD98-48E6-9C8F-395E9E271F0B Q39095070-070530F2-3D3F-4357-AED2-126DF86A129D Q40626615-DAE6B09D-505E-4A38-8363-3DB06D0BB328 Q40688778-65992263-9199-4859-8FE5-9A67B63C607A Q46242881-0368519D-CDEE-41AF-BFEC-5D1E47ED1B8B Q46246072-0D874A5A-5726-4436-ACD8-C596C9380C4F Q48301307-52B289CD-C021-4AE5-A0ED-27210A33A4F6 Q51604294-08D563AC-0D85-4118-8F27-745D6AA30D44 Q51732186-4B99DB2B-6198-4D5A-AF0E-DB8116CF4D0D Q52564632-7025DF28-0BC3-4E8D-AFD4-6E37AB4CF4F9 Q53632800-82DAAE99-D5BD-48B9-ACDF-58C39533CD6E Q54264166-9143E6D2-B0D2-4CDC-9A52-7EF1115E6871 Q55092065-707ADCA1-8865-41C7-B3CD-FE6901A09A53 Q55498067-FAE94C04-CC76-444E-BD92-22104EBECA63 Q55605649-71D4D9A0-F43C-49DA-949D-14D71AC1CA7D Q57072837-8BE1AD3C-BE83-490D-AF20-C9D568D175D3 Q58758259-7CB879EE-64CD-428F-BDB0-912F3ABE510C

P2860

Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial

http://www.wikidata.org/entity/Q35105984

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Disrupted intestinal microbiot ...... G: a randomised clinical trial

@ast

Disrupted intestinal microbiot ...... G: a randomised clinical trial

@en

type

label

Disrupted intestinal microbiot ...... G: a randomised clinical trial

@ast

Disrupted intestinal microbiot ...... G: a randomised clinical trial

@en

prefLabel

Disrupted intestinal microbiot ...... G: a randomised clinical trial

@ast

Disrupted intestinal microbiot ...... G: a randomised clinical trial

@en

P1433

Q35105984-F626875D-F8ED-4FCD-8A70-5334DE716D15

P1476

Q35105984-26BFBCEC-8523-42C4-8C95-F11EE19AF873

P2093

Q35105984-00DF338F-C8EA-4F4D-ADEA-F8E44DCF698A

Q35105984-0B92E1A1-CF63-4D51-B391-343969E8317E

Q35105984-1EFBE9DD-F86B-42BA-8A10-5F4DB73686FC

Q35105984-2E4FF0E9-1C4D-4528-B9D8-3F08806C11E9

Q35105984-594D8D54-4F13-4F4F-97A1-F2A6CD53A046

Q35105984-9DF1D6B3-CB1E-4BB3-8555-6FA9121CB084

Q35105984-A0B51A13-51F3-461B-946B-D134478EFADF

Q35105984-B300A5FE-9214-4E67-9011-91BBCD56B019

Q35105984-E7F5E12A-3287-41CC-BD2C-5FC6C74B525F

P2860

Q35105984-128396CF-CD86-4A5E-BA37-FEE25607DDA1

Q35105984-27190901-2369-4371-98AC-C2AB7CBFF49F

Q35105984-311B13C6-4BA6-4E17-9534-BA6CA30F3B2A

Q35105984-343B12ED-0B95-42F6-BABB-F9081713646E

Q35105984-443FDC91-9731-4C1D-BC02-C3379DACCBB4

Q35105984-485AD3EC-B4C9-4625-A0E0-CD7DDA14E110

Q35105984-49AA6F90-7AC3-454F-8E55-DF34294603FD

Q35105984-4DDFB16A-ED97-4587-9B27-F30F8F23A4E4

Q35105984-666FA337-C080-4F70-A325-9244681F6739

Q35105984-68A847DB-8D03-492D-9B33-C1C180D2E92E

P304

Q35105984-BDDC2031-38F7-48B3-9679-32D5EEEBB30E

P31

Q35105984-87AF1E04-9D00-4F07-AC6C-EA9573C2DDF0

P356

Q35105984-4B34F7D3-CB7C-4579-9F43-DBA6B15A3876

P433

Q35105984-4A5DA493-293D-488D-A199-13084C4A2BCB

P478

Q35105984-AC1D4356-E31A-4145-BF99-9D936A8B0A4B

P50

Q35105984-CB8BDBD6-D3CE-46A8-8509-30E2135EE249

Q35105984-E69177C3-F391-4B86-877B-A0D366FD21EF

P577

Q35105984-F1A11B42-1592-44D1-9D77-08129871587A

P5875

Q35105984-320FBA22-22E0-4C90-8817-A1FCC3F05DCA

P698

Q35105984-88725C1C-5149-4D9C-BC43-79850A3E412A

P921

Q35105984-53859102-5118-483D-AD42-C118A7BF09E0

P932

Q35105984-AB766866-1CBB-4DA4-8FFA-286A4D2B5E84

P356

JOURNAL.PONE.0087796

P1433

P1476

Disrupted intestinal microbiot ...... G: a randomised clinical trial

@en

P2093

Andrea Lo Vecchio

http://www.w3.org/2001/XMLSchema#string

Eliana Ruberto

http://www.w3.org/2001/XMLSchema#string

Eugenia Bruzzese

http://www.w3.org/2001/XMLSchema#string

Lorenzo Morelli

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Callegari

http://www.w3.org/2001/XMLSchema#string

Sara Viscovo

http://www.w3.org/2001/XMLSchema#string

Susanna Ferrari

http://www.w3.org/2001/XMLSchema#string

Valeria Raia

http://www.w3.org/2001/XMLSchema#string

Vittoria Buccigrossi

http://www.w3.org/2001/XMLSchema#string

P2860

A core gut microbiome in obese and lean twins

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

Bacterial flora in inflammatory bowel disease

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.

Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.

Molecular analysis of the gut microbiota of identical twins with Crohn's disease.

Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome.

P304

e87796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0087796

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Alfredo Guarino

Riccardo Scotto

P577

2014-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260447476

http://www.w3.org/2001/XMLSchema#string

P698

24586292

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

3929570

http://www.w3.org/2001/XMLSchema#string